<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>15099590229146</udiDi>
    <basicUdiDi>150995901AccIFAbZ2</basicUdiDi>
    <tradeName>Access Intrinsic Factor Antibody</tradeName>
    <deviceName>Access Intrinsic Factor Antibody</deviceName>
    <manufacturerName>Beckman Coulter Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000010288</manufacturerSrn>
    <authorisedRepresentativeName>Beckman Coulter Ireland Inc.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IE-AR-000000886</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0102070205</emdnCode>
    <emdnDescription>INTRINSIC FACTOR (BLOCKING ANTIBODY)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>387992</reference>
    <placedOnMarketCountry>Ireland</placedOnMarketCountry>
    <lastUpdated>2026-07-30T17:34:32.496Z</lastUpdated>
  </row>
  <row>
    <udiDi>06975070767723</udiDi>
    <basicUdiDi>B-06975070767723</basicUdiDi>
    <tradeName>Sharay Anti-IF IgG (CLIA)</tradeName>
    <deviceName>Sharay Anti-IF IgG (CLIA)</deviceName>
    <manufacturerName>C-Luminary Biotechnology Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000035089</manufacturerSrn>
    <authorisedRepresentativeName>Sungo Cert GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000010869</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0102070205</emdnCode>
    <emdnDescription>INTRINSIC FACTOR (BLOCKING ANTIBODY)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>18159002</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-06T18:46:14.266Z</lastUpdated>
  </row>
  <row>
    <udiDi>04049325004207</udiDi>
    <basicUdiDi>B-04049325004207</basicUdiDi>
    <tradeName>Intrinsic Factor-Ab ELISA</tradeName>
    <deviceName>Intrinsic Factor-Ab ELISA</deviceName>
    <manufacturerName>IBL International GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000015709</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W0102070205</emdnCode>
    <emdnDescription>INTRINSIC FACTOR (BLOCKING ANTIBODY)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>RE70881</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-06T00:09:18.125Z</lastUpdated>
  </row>
  <row>
    <udiDi>07333066015774</udiDi>
    <basicUdiDi>7333066BUDI0124LZ</basicUdiDi>
    <tradeName>EliA Intrinsic Factor Well</tradeName>
    <deviceName>EliA Intrinsic Factor</deviceName>
    <manufacturerName>Phadia AB</manufacturerName>
    <manufacturerSrn>SE-MF-000014170</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0102070205</emdnCode>
    <emdnDescription>INTRINSIC FACTOR (BLOCKING ANTIBODY)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>14-5668-01</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-03T01:17:29.802Z</lastUpdated>
  </row>
</eudamedExport>